Association between Chlamydia pneumoniae and atherosclerotic lesions

Cardiovascular Journal of South Africa

Volumn 12, Issue 1, 2001, Pages 42-46

  Phillips, J I ^a   Shor, A ^a  

^a National Centre for Occupational Health   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC THERAPY; ANTIBODY TITER; ATHEROSCLEROSIS; CELL VIABILITY; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; HUMAN; IMMUNOHISTOCHEMISTRY; REVIEW; RISK BENEFIT ANALYSIS; TISSUE DISTRIBUTION;

CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERIOSCLEROSIS; HUMANS;

EID: 0034841046     PISSN: 10159657     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Chlamydia pneumoniae in arteries: The facts, their interpretation, and future studies
2. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections
3. Infections caused by Chlamydia pneumoniae strain TWAR
4. Chlamydia pneumoniae may be associated with lung cancer. Preliminary report on a seroepidemiological study
5. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
6. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis
7. Chlamydia pneumoniae and coronary heart disease
8. Epidemiology of Chlamydia pneumoniae in atherosclerosis
9. Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus: Chronic infections and coronary heart disease
10. Chronic infection and coronary artery disease
11. Current knowledge of Chlamydia pneumoniae and atherosclerosis
12. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction
13. Serological evidence of Chlamydia pneumoniae lipopolysaccharide antibodies in atherosclerosis of various vascular regions
14. The progression of lower limb atherosclerosis is associated with IgA antibodies against Chlamydia pneumoniae
15. Immunoglobulin A antibodies against Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysm
16. Relation of C. pneumoniae antibodies to ischaemic heart disease
17. Myocardial infarction associated with Chlamydia pneumoniae: A case report
18. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques
19. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries
20. Chlamydia pneumoniae in arteries: A tale of the unexpected
21. Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients
22. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy
23. Failure to demonstrate Chlamydia pneumoniae in symptomatic abdominal aortic aneurysms by a nested polymerase chain reaction (PCR)
24. Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms
25. The role of Chlamydia pneumoniae in atherosclerosis
26. Molecular diagnosis of Chlamydia pneumoniae infection
27. The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis
28. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery
29. Multiple infections in carotid atherosclerotic plaques
30. Infections, inflammation, and the risk of coronary heart disease
31. Chronic infections and coronary heart disease
32. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not
33. Atherosclerosis, inflammation, and infection
34. Chlamydia pneumoniae in atheroma: Consideration of criteria for causality
35. Risk factors for coronary heart disease and infection with Helicobacter pylori: Meta-analysis of 18 studies
36. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms
37. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications
38. Chlamydia pneumoniae in human abdominal aortic aneurysms
39. Detection of Chlamydia pneumoniae by colorimetric in situ hybridization
40. Detection of Chlamydia pneumoniae DNA in atheromatous tissues by polymerase chain reaction
41. Immunohistochemical detection of Chlamydia pneumoniae in abdominal aortic aneurysms
42. Detection of Chlamydia pneumoniae in human nonrheumatic stenotic aortic valves
43. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis
44. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease
45. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen
46. Detection of Chlamydia pneumoniae but not cytomegalovirus in occluded saphenous vein coronary artery bypass grafts
47. Demonstration of viable Chlamydia pneumoniae in atherosclerotic plaques of carotid arteries by reverse transcriptase polymerase chain reaction
48. Chlamydia pneumoniae and atherosclerosis
49. Does Chlamydia pneumoniae cause coronary heart disease?
50. Chlamydia in coronary plaques - Hidden culprit or harmless hobo?
51. Is infection with Chlamydia pneumoniae a causative agent in atherosclerosis?
52. The prevalence of Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic blood vessels of patients attending for redo and first time coronary artery bypass graft surgery
53. Histological and ultrastructural findings suggesting an initiating role for Chlamydia pneumoniae in the pathogenesis of atherosclerosis: A study of fifty cases
54. Fulfillment of Koch's postulates and the causes of atherosclerosis
55. Secondary prevention trials for coronary artery disease with antibiotic treatment for Chlamydia pneumoniae: Design issues
56. Chlamydia pneumoniae infection and coronary heart disease. Trials should assess whether antibiotics eliminate organism from atherosclerotic lesions
57. Chronic infection in the aetiology of atherosclerosis - Focus on Chlamydiapneumoniae
58. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study
59. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction
60. Treatment of Helicobacter pytori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischaemic heart disease
61. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study
62. Emerging role of antibiotics in atherosclerosis
63. Chlamydia pneumoniae, monocyte activation, and azithromycin in coronary heart disease
64. WIZARD and the design of trials for secondary prevention of atherosclerosis with antibiotics
65. Antibiotics and risk of subsequent first-time acute myocardial infarction
66. Antibiotic use and risk of myocardial infarction
67. Animal models of chlamydia and atherosclerosis
68. Mouse models of Chlamydia pneumoniae infection and atherosclerosis
69. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model
70. Atherosclerosis - An inflammatory disease
71. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association
72. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association
73. C-reactive protein, inflammation, and coronary risk
74. Persistence of Chlamydia pneumoniae, in coronary plaque tissue. A contribution to infection and immune hypothesis in unstable angina pectoris
75. Chlamydia pneumoniae in coronary plaques: Increased detection with acute coronary syndrome
76. Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (Stary grading) of associated atherosclerotic plaque
77. Distribution of Chlamydia pneumoniae, infection in the atherosclerotic carotid artery
78. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain
79. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old)
80. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues
81. Chlamydia pneumoniae and coronary heart disease
82. Macrophage scavenger receptor class A: A multifunctional receptor in atherosclerosis
83. Atherosclerosis
84. Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis
85. Preatheroma phase of coronary atherosclerosis in man
86. The morphogenesis and fate of potential and early atherosclerotic lesions in man